| Biography | Ralph Loren, a partner at Edward Wildman Palmer, has practiced in all phases of intellectual property for over 30 years. His practice is primarily in litigation and deal work with an emphasis on licensing and due diligence. He has many years of patent prosecution experience, primarily in the life sciences and computer fields. He has litigated numerous patent infringement actions in diverse fields including biotechnology, chemical analyzers, computers, electronic equipment and mechanical devices. He has been involved in a number of interferences in the biotechnology and chemical/mechanical field. He has also litigated numerous trademark and copyright matters. His deal experience ranges from M&A and licensing in the pharma space to licensing and due diligence in the software field. Ralph lectures around the country on a variety of patent, licensing and litigation topics, including arbitration issues. He was a part-time professor at Boston University School of Law, where he taught patent law. He was also the author of a chapter entitled "Alternative Dispute Resolution" in the multi-volume Mathew Bender series, "Intellectual Property Counseling and Litigation." He is listed as one of the leading Intellectual Property Attorneys in Massachusetts in Chambers USA and has been included in the Massachusetts Super Lawyers listing, a Thomson Reuters publication, numerous times. Recent Speaking Engagements and Publications · "Computers and the Law: Intellectual Property: Part One," co-author, Computer Magazine, Vol. 45, No. 1, January 12, 2012, pp. 14-16. · "Computers and the Law: Intellectual Property: Part One," speaker, Computer Magazine podcast, January 2012. · "Patent Law Reform," speaker, Boston Patent Law Association, September 28, 2011. · "Obama Signs U.S. Patent Reform into Law," co-author, Edwards Angell Palmer & Dodge Client Advisory, September 16, 2011. · "IP Basics," speaker, Ethics and Compliance Officers Association Law School Webcast, September 7, 2011. · "Licensing Strategies for Biosimilars: Regulatory, Commercial and IP Considerations for the New Frontier," speaker, American Conference Institute's 15th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions, San Francisco, California, July 21, 2011. · "New Law! The Biologics Price Competition and Innovation Act of 2009," co-author, Edwards Angell Palmer & Dodge Client Advisory, March 2010. · "Anticipating Future Technologies and Incorporating Terms into the Agreement to Protect Future Rights," speaker, American Conference Institute's 12th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements, San Francisco, California, July 15, 2009. · "Leveraging and Safeguarding IP Rights During Negotiations," co-presenter, American Conference Institute's Pharma and Biotech Collaborative Agreements, San Francisco, California, July 16, 2007. · "Freedom to Operate: Review of Analysis and Opinions for Pharma and Biotech Patents," presenter, American Conference Institute's Pharma and Biotech Patent Boot Camp, New York, June 21-22, 2007. · "Has new decision revitalized opinions?" co-author, Mass High Tech, April 13, 2007. · "The Master Class on Drafting Successful Patent Applications for Biotechnology Related Inventions," workshop co-leader, ACI's 9th Advanced Forum on Biotech Patents, Boston, Massachusetts, scheduled for September 28, 2007. · "Is Apple's iPhone An iProblem?" co-author, Edwards Angell Palmer & Dodge Intellectual Property Bulletin, Spring 2007. · "The Master Class on Drafting Successful Patent Applications for Biotechnology Related Inventions," workshop co-leader, ACI 7th Advanced Forum on Biotech Patents, Boston, Massachusetts, November 29 - December 1, 2006. · "Analyzing and Managing Pipeline Development Strategies", co-presenter, American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements Conference, November 14, 2005. News & Publications January 2012, In Article and Podcast, Edwards Wildman Team Provides IP Primer for Computer Magazine September 16, 2011, Client Advisory - Obama Signs U.S. Patent Reform into Law June 21, 2011, Edwards Angell Palmer & Dodge Recognized by Chambers USA in 17 Categories October 7, 2010, EAPD Attorneys Selected For Inclusion in Super Lawyers 2010 June 23, 2010, Chambers and Partners Recognizes EAPD in Nineteen Areas March 2010, Client Advisory - New Law! The Biologics Price Competition and Innovation Act of 2009 March 1, 2010, EAPD Attorneys Recognized in 2010 Super Lawyers Corporate Counsel Edition November 6, 2009, EAPD Attorneys Selected For Inclusion in Super Lawyers 2009 July 7, 2008, Edwards Angell Palmer & Dodge Recognized in the American Lawyer April 10, 2008, EAPD Represents Takeda Pharmaceutical Company Limited in $8.8 Billion Acquisition of Millennium Pharmaceuticals April 17, 2007, Intellectual Property Bulletin - Spring 2007
Edwards Angell Palmer & Dodge LLP April 13, 2007, Has new decision revitalized opinions? January 2, 2007, Ten Attorneys Admitted As Partners of Edwards Angell Palmer & Dodge Events 15 February 2012, IP INTERAction Conference
New Threats and New Opportunities: What IP Owners Should Be Doing Now January 31 - February 1, 2012, New York, NY, The Comprehensive Guide to Patent Reform For Life Sciences Companies July 20-21, 2011, San Francisco, CA, ACI's 15th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions July 14-15, 2009, San Francisco, CA, 12th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements September 26, 2007 - September 28, 2007, Boston, MA, ACI's 9th Advanced Forum on Biotech Patents
Analysis, Insights and Strategies for New Challenges in Biotech Patent Practice July 16, 2007 - July 17, 2007, San Francisco, CA, ACI's Pharma and Biotech Collaborative Agreements
Allocating Risk, Responsibilities & Rewards in In-Licensing, Co-Development & Co-Promotion Deals November 29, 2006 - December 1, 2006, Boston, MA, ACI 7th Advanced Forum on Biotech Patents September 26, 2006 - September 28, 2006, Philadelphia, PA, Pharmaceutical & Biotech Patent Strategies
Extending Patent Life Cycles and Protecting IP in a Changing, Competitive Environment November 14, 2005, Philadelphia, PA, Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements Industries · Life Sciences · Education · Healthcare Memberships · American Bar Association · Boston Bar Association · Boston Patent Law Association · American Intellectual Property Law Association |